Best Traditional Life Sciences Platforms & Tools Companies in United States
The 173 best Traditional Life Sciences Platforms & Tools companies in United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Invitrogen.
The 173 Traditional Life Sciences Platforms & Tools companies tracked here in the United States represent a sector where the real story is earned revenue, not headlines. Six filers alone generated a combined $14.4B revenue pool, with Thermo Fisher Scientific leading at $11.0B, up 6% year-over-year. Avantor checked in at $1.6B, and Perrigo posted $933M on a striking 21% YoY gain. Median revenue across those filers sits at $889M. That's the floor you're measuring against.
The $299M in total disclosed funding across these 173 companies looks modest against a global market forecast to grow from $89.4B to $183.8B by 2027 at a 10.8% CAGR, driven by advances in quantitative accuracy and mass spectrometry resolution. So where does early-stage U.S. capital actually concentrate? Meso Scale Diagnostics leads directory funding at $13M, with Tau Systems close behind at $15M, and government-linked backers like the National Science Foundation and HHS are doing real work here. Regulatory challenges remain a structural drag, I'd note, but median revenue growth of 3% YoY across filers suggests a sector that compounds quietly rather than spectacularly.
- Precedence Research
Ranked: Best Traditional Life Sciences Platforms & Tools companies in United States
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Market signals (1y) | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Invitrogen Manufacturer of laboratory instruments, equipment, reagents, and related consumables | $172M | — | 124 | William McConnell Co-Founder | — | — | 667 patents Molecular biology reagents, nucleic acid manipulation, assay kits, and cell‑culture media | — |
| 2 | Rees Scientific Provider of environmental monitoring systems and services. | $27M | 43 mo ago | 136 136 → 208 (+53%) | — | DrupalApple iCloud MailMicrosoft 365+17 | — | — | — |
| 3 | MitoKor Manufacturer of mitochondrial genomes | $25M | 293 mo ago | — | Walter H Moos CEO | — | — | — | — |
| 4 | TAU Systems Manufacturer of x-ray free electron lasers | $15M | 13 mo ago | 18 | — | Apple iCloud MailMicrosoft 365PHP+5 | — | — | — |
| 5 | MESO SCALE DIAGNOSTICS Innovative assays and instruments for biological sample molecule measurement | $13M | 13 mo ago | 996 | — | Cart FunctionalitySalesforceWindows Server+9 | — | — | 2 launchs · 1 partnership |
| 6 | Copan Innovating specimen collection, transport, laboratory automation, and AI for healthcare | $10M | 73 mo ago | 136 136 → 175 (+29%) | Fabrizio Mazzocchi Chief Executive Officer | WordPressMySQLPHP+14 | — | — | — |
| 7 | Ronawk Manufacturer of cell & tissue propagating platform | $8M | 37 mo ago | 3 | Heather Decker Co-Founder | WordPressApple iCloud MailMicrosoft 365+21 | — | 57 patents 3D porous hydrogel block platforms for scalable cell culture and tissue engineering | — |
| 8 | QATCH Technologies CRO focused on providing early stage drug development services | $6M | 15 mo ago | 6 | — | — | — | — | 1 launch |
| 9 | Boston Cell Standards Manufacturer of IHC testing products | $5M | 16 mo ago | 6 | Steve Bogen Co-Founder & President & CEO | — | — | — | — |
| 10 | Fluxa Provider of AI, IoT and cloud consulting services | $5M | 63 mo ago | 16 | — | — | — | — | — |
| 11 | SolarBiotech Developer of modular plant architectures for sustainable SynBio product biomanufacturing | $2M | 48 mo ago | 28 | — | — | — | — | — |
| 12 | MONSTR Sense Develops ultrafast spectrometers and microscopes | $2M | 15 mo ago | 4 | Steve Cundiff Co-Founder | WordPressMySQLPHP+20 | — | — | — |
| 13 | PHI Manufacturer of holographic imaging devices | $1M | 20 mo ago | 14 | — | WordPress Block EditorWordPressMySQL+10 | — | — | — |
| 14 | EnTox Provider of analytical tools for research and drug development | $1M | 86 mo ago | — | Ian Sweet CEO | — | — | 4 patents Soluble clinoptilolite fragments for pharma, nutraceutical and environmental remediation applications. | — |
| 15 | Gmj Technologies Manufacturer of protein characterization tools | $996K | 64 mo ago | — | Tosin Dada CEO | — | — | — | — |
| 16 | AvanSci Bio Bioinformatics, reagents, and assays for research, diagnostics, and therapeutics | $960K | 145 mo ago | 6 | Rob Parry Co-Founder and Chief Executive Officer | — | — | — | — |
| 17 | Advanced Instruments Manufacturer of Laboratory equipment | $793K | 84 mo ago | 495 | John Coughlin President & CEO | Cart FunctionalityWordPressApple iCloud Mail+25 | — | — | — |
| 18 | Blueshift Optics Manufacturer of organic glass scintillator for neutron detection | $711K | 52 mo ago | 2 | — | — | — | — | — |
| 19 | Higher Enterprises Manufacturer of control & COD measuring devices, spectrophotometer, and test kits 53Talent top 27%Tech top 31%Partners top 33%Market top 36% All 8 signals ▾Talenttop 27% Techtop 31% Partnerstop 33% Markettop 36% Newsbottom 45% Growthbottom 32% Fundingbottom 31% Globalbottom 25% Talent: 3 named leaders on record · 3 C-suite/founder profiles curated Tech: 41 technologies across 5/8 capability areas · Cloud: Akamai, Amazon Cloudfront rank vs industry peers · Fliar Intelligence Index 53/100 | $600K | 82 mo ago | — | Harold Eason Co-CEO | DrupalApple iCloud MailMicrosoft 365+15 | 15 signals ▼67% Lawsuit · Leadership | — | 6 job openings |
| 20 | Stone Medical Corporation Developer of blood collection systems | $525K | 127 mo ago | — | Benjamin Stone Founder & CEO | — | — | — | — |
| 21 | Biorealize Promoter of Arabic language and literature through various initiatives | $325K | 77 mo ago | 5 | Michael Hogan Co-Founder | — | — | 3 patents Portable bioreactor systems for on‑site biofilm formation and degradation analysis | — |
| 22 | Vigilant Diagnostics Manufacturer of clinical detection equipment | $301K | 104 mo ago | — | John Bischof Co-Founder | — | — | — | 1 launch |
| 23 | Peak Thermal Manufacturer and global supplier of power-efficient cooling systems for urgent medical vaccines | $300K | 33 mo ago | — | Jon Nakagawa Founder & CEO | — | — | — | — |
| 24 | Quicksilver Biosciences Provider of CMOS-integrated biosensor platform for rapid genomic identification | $256K | 69 mo ago | 5 | — | — | — | — | — |
| 25 | SurgiReal Manufacturer of realistic medical simulation tools for surgical training. | $200K | 55 mo ago | 11 | Dean Hendrickson Co-Founder | Cart FunctionalityShopifyBugHerd+19 | — | — | — |
| 26 | Akron Biotech Manufacturer of cGMP-compliant ancillary materials for cell and gene therapies | $154K | 108 mo ago | 58 58 → 102 (+76%) | — | Craft CMSApple iCloud MailPHP+20 | — | — | 1 job opening · 2 launchs |
| 27 | Gnosko Bio Manufacturer of laboratory consumables and chemicals | $100K | 25 mo ago | — | Wills Wendel Founder & CEO | — | — | — | 1 award |
| 28 | SeeTrue Develops easy-to-use microcapillary needles for improved precision and outcomes | $100K | 41 mo ago | 4 | — | — | — | — | — |
| 29 | Acorn Genetics Manufacturer of portable genetic sequencer | $50K | 14 mo ago | 6 | Ana Cornell Founder & CEO | — | — | — | 1 partnership |
| 30 | Scientific Industries Provider of an online store for selling laboratory products | — | 14 mo ago | 84 | — | Cart FunctionalityMagentoMySQL+21 | 9 signals ▲350% Earnings · Acquisition | 34 patents Medical endoscopic accessories and conductive optical components for device delivery and cleaning. | — |
| 31 | Sigma Aldrich Developer of biochemical and organic chemicals | — | 29 mo ago | 4,709 | Alfred Bader Co-Founder | Microsoft Visual StudioMicrosoft ASP.NETHSTS | — | 1,232 patents Patents concentrated in chemistry & materials | — |
| 32 | Thermo Fisher Scientific Provider of electron microscopy services | — | 30 mo ago | — | Srinath Venkatesh Managing Director & VP/GM- India and South Asia | Adobe Experience ManagerApple iCloud MailJava+20 | — | — | — |
| 33 | Parhelia Bio Provider of cost-effective, precision, customizable tissue staining automation solutions for biomedical… | — | 32 mo ago | 10 | Yury Goltsev Co-Founder | WebflowSentryWistia+22 | — | — | — |
| 34 | Waters Corporation Provider of laboratory management system for researchers and clinicians | — | 54 mo ago | 7,900 | Udit Batra CEO & President | Cart FunctionalityAdobe Experience ManagerJava+30 | 15 signals ▼38% Earnings · M&A · Regulatory | 3,331 patents Advanced liquid chromatography media, devices, and methods for biomolecule analysis | — |
Top 12 Traditional Life Sciences Platforms & Tools companies in United States
#1
Funding Raised · Rockville, Maryland · founded 1995 · 996 employees$13.1Mraised▾
Innovative assays and instruments for biological sample molecule measurement. The company develops, manufactures, and commercializes innovative assays and instruments. Its proprietary MULTI-ARRAY technology enhances medical research and drug development by enabling researchers to profile many biomarkers simultaneously in a single sample without compromising assay performance. The technology has been widely adopted by researchers in pharmaceutical companies, government institutions, universities, and clinical laboratories worldwide for its high sensitivity, excellent reproducibility, and wide dynamic range. The company continues to evolve its technology platform to enable researchers to solve complex biological questions and is expanding into clinical applications and the emerging fields of personalized medicine and companion diagnostics. The company offers immunoassay analyzers equipment, assay development, immunogenicity testing, custom conjugation services, and assay analysis software.
- Apr 2025Grant (prize money)$3.3M
- Sep 2022Grant (prize money)$2.1M
- Sep 2014Grant (prize money)$297.8K
- Sep 2012Grant (prize money)$784.4K
#2
Seed · Austin, Texas · founded 2021 · 18 employees$15Mraised▾
Manufacturer of x-ray free electron lasers
#3
Funding Raised · Durham, North Carolina · founded 2016 · 6 employees$5.6Mraised▾
QATCH Technologies is a life-science instrumentation start-up, and was founded to commercialize a sensor technology developed at Duke University. QATCH is currently developing a tool to prescreen injectability and manufacturability of biopharmaceutical drugs at an early stage of drug development due to the very low volume needed (μLs). QATCH's proprietary technology can de-risk preclinical phase for biopharmaceutical drug development and prevent delays for crucial medicines reaching patients.
- Mar 2025Grant (prize money)$1.5M
- Sep 2023Grant (prize money)$1.9M
- Feb 2022Grant (prize money)$1.5M
- Sep 2020Grant (prize money)$255.7K
#4
Funding Raised · Boston, Massachusetts · founded 2003 · 6 employees$5.4Mraised▾
Manufacturer of IHC testing products
- Feb 2025Grant (prize money)$2M
- Sep 2021Grant (prize money)$2M
- May 2015Grant (prize money)$1.4M
#5
Funding Raised · Ann Arbor, Michigan · founded 2018 · 4 employees$1.7Mraised▾
Develops ultrafast spectrometers and microscopes
- Mar 2025Grant (prize money)$1.5M
- May 2020Grant (prize money)$225K
#6
Public · Boston, Massachusetts · founded 2004 · 14 employees$1.4Mraised▾
Manufacturer of holographic imaging devices
- Oct 2024Post IPO$504.8K
- May 2024Conventional Debt$654.9K
- Apr 2017Grant (prize money)$281K
#7
Funding Raised · Evanston, Illinois · founded 2019 · 6 employees$50Kraised▾
Developer of a novel third-generation genetic sequencing method intended to make genetic testing secure, accessible, and affordable to all people. The company's services include delivering at-home genetic testing through a fast and precise genetic sequencer, enabling clients to take action to beat diseases such as cancer, Alzheimer's, and heart disease years before it start to affect their lives.
- Apr 2025Grant (prize money)$50K
#8
Acquired · Trenton, New Jersey · founded 1982 · 136 employees$27.2Mraised▾
{}
- Nov 2022Series B$27.2M
#9
Series A · Olathe, Kansas · founded 2019 · 3 employees$7.9Mraised▾
Manufacturer of cell & tissue propagating platform
- May 2023Series A$6M
- Dec 2022Seed$1.9M
#10
Public · Carlsbad, California · founded 1987 · 124 employees$172.5Mraised▾
Manufacturer of laboratory instruments, equipment, reagents, and related consumables. It offers products for chromatography, mass spectrometry, cell culture, and next-generation sequencing. The company provides services, including lab instrument support, custom services, and training. It also offers enterprise-level lab informatics, partnering, and licensing services.
- PE$172.5M
#11
Series A · San Diego, California · founded 1992$25Mraised▾
Developer of therapeutic solutions for diseases. The company focuses on developing diagnostic metrics and therapeutics for diseases caused or affected by abnormalities in the mitochondrial genome.
- Dec 2001Series A$25M
#12
Funding Raised · Murrieta, California · founded 1994 · 136 employees$10Mraised▾
Innovating specimen collection, transport, laboratory automation, and AI for healthcare. The company transforms pre-analytics with innovative solutions for sample collection, transport devices, and laboratory essentials. They offer a range of products including flocked swabs, transport systems, enrichment broths, and laboratory supplies. The company provides laboratory automation and AI solutions, such as microbiology laboratory automation, specimen aliquoting automation, and pharma & food safety automation. They focus on collaborative partnerships with customers, offering cutting-edge technology and solutions for the betterment of the healthcare diagnostics industry. Their commitment extends to providing accurate and timely results, improving patient care through innovation in the pre-analytical phase. The company emphasizes innovation, collaboration, and a customer-focused approach to meet laboratory needs and drive the future of diagnostics.
- May 2020Grant (prize money)$10M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Traditional Life Sciences Platforms & Tools coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.